DEVELOPMENT AND CHARACTERIZATION OF ANTI-RCC x ANTI-DTPA BISPECIFIC MONOCLONAL ANTIBODIES FOR TWO-PHASE TARGETING OF RENAL CELL CARCINOMA

Abstract
No abstract available